PubMed Health⌕ Search

Biomedical subjects

B Bigler

Publications and source records attributed to B Bigler.

9 recordsLinked to original sources

Vr2: a new apple scab resistance gene.

Reports from several European countries of the breakdown of the Vf resistance, the most frequently used source of resistance in breeding programs against apple scab, emphasize the urgency of diversifying the basis of apple scab resistance and pyramiding different apple scab resistances with the use of their associated molecular markers. GMAL 2473 is an apple scab resistant selection thought to carry the resistance gene Vr. We report the identification by BSA of three AFLP markers and one RAPD marker associated with the GMAL 2473 resistance gene. SSRs associated with the resistance gene were found by (1) identifying the linkage group carrying the apple scab resistance and (2) testing the SSRs previously mapped in the same region. One such SSR, CH02c02a, mapped on linkage group 2, co-segregates with the resistance gene. GAML 2473 was tested with molecular markers associated with other apple scab resistance genes, and accessions carrying known apple scab resistance genes were tested with the SSR linked to the resistance gene found in GMAL 2473. The results indicate that GMAL 2473 does not carry Vr, and that a new apple scab resistance gene, named Vr2, has been identified.

Ascomycota↗

Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the serological diagnosis of sarcoptic mange in dogs.

Canine scabies is a challenging disease to diagnose because sarcoptic mites are hard to find on skin scrapings. The purpose of this study was to evaluate a serologic enzyme-linked immunosorbent assay (ELISA) as an aid in the diagnosis of canine scabies. In addition, serum samples were obtained post treatment to determine the duration and persistence of circulating scabies antibodies after resolution of natural infection. Nineteen dogs diagnosed with sarcoptic mange and 38 control dogs were tested. Sixteen scabies-infested dogs showed positive pretreatment ELISA results (84.2% sensitivity). Thirty-four control dogs showed negative ELISA results (89.5% specificity). In the 11 scabies dogs from which multiple post treatment serum samples were obtained, detectable antibodies were not present 1 month after treatment in four cases, but were present for 1-4.5 months post treatment in seven dogs. Our results suggest that this scabies ELISA test is useful in the diagnosis of canine scabies.

Animals↗

Morphological studies in dogs with chronic pancreatic insufficiency.

The pancreas of dogs with the clinical syndrome of chronic pancreatic insufficiency was examined macroscopically, by light- and electron microscopy and immunohistochemically. The pancreatic tissue was reduced in volume, the lobular architecture was disturbed and the ductal system prominent. Many acini were shrunken and contained cells with pyknotic nuclei. The islets of Langerhans were highly irregular, often difficult to identify. Many B cells occurred isolated within the exocrine tissue. Ultrastructurally, changes in the acinar cells included alterations in the chromatin pattern and dilatation of the cisternae of the rough endoplasmic reticulum. In endocrine cells nuclear deformations, chromatin condensation and progressive loss of secretory granules were seen, accompanied by vacuolization of the cytoplasm. The changes included all endocrine cell types. This complex of pancreatic lesions is considered to be of degenerative origin. The aetiology of the disease is unknown.

Animals↗